Lynx Equity defends AMAT and LRCX stocks amid pressures By Investing.com

Lynx Equity reiterated bullish targets on Applied Materials at $540 and Lam Research at $325, citing favorable multi-year NAND, DRAM, and advanced logic wafer fabrication equipment cycles. Applied Materials also drew support from recent upside to its 2026 outlook, including Semi Systems revenue growth guidance above 30% and stronger AI-cycle positioning. The stock has already returned 166% over the past year and trades at $414.65, while Wall Street consensus remains constructive with a 1.51 rating and targets ranging from $355 to $575.

Analysis

The key signal is not simply that semicap sentiment is improving; it’s that the earnings cycle is re-accelerating into an environment where positioning was still skeptical. That matters because AMAT and LRCX are operating as high-beta claims on multi-year capex rather than just near-term order flow, so incremental upgrades can force systematic re-rating if guidance proves durable into the next two quarters. In this setup, the winners are not only the equipment leaders but also adjacent process/control vendors and substrate/material suppliers that typically lag the first move and then catch up as bookings visibility improves.

The second-order dynamic is that AI infrastructure spending is likely broadening from GPUs and packaging into upstream fab capacity, which is the part the market tends to underappreciate until margins and backlog data confirm it. If the NAND cycle inflects into 2027-2028 as expected, LRCX has optionality on a longer-duration earnings runway, but that also means the name is more sensitive to any delay in memory capex recovery. MS looks neutral here, but a stronger WFE tape can still leak into its precision fabrication franchise through improved industrial semiconductor demand and tighter customer budgets.

The main risk is that consensus may be extrapolating a cycle that is still fragile on the demand side. A 1-2 quarter pause in foundry/logic spending or a memory capex hiccup would hit semicap multiples fast because the names are already priced for sustained execution, not just stabilization. Near term, the trade is more about multiple expansion on guidance durability; over 6-18 months, the risk is that the market has already pulled forward 2026-2028 optimism and leaves little room for disappointment.

The contrarian read is that the bullish case may be over-concentrated in AMAT as the cleanest AI beneficiary, while LRCX offers better asymmetry if memory does recover on schedule. If the market continues to treat all semicap strength as one-factor AI beta, relative value should favor the laggard with deferred cycle leverage rather than chasing the most obvious winner after a large run.

Key Decisions for Investors

• Long AMAT on 1-3 month horizon via stock or call spreads; use pullbacks toward support to enter. Risk/reward is strongest if the market re-prices 2026 guidance durability, but trim if the name loses follow-through after the next analyst upgrade wave.
• Initiate a relative-value pair: long LRCX / short a semicap basket or higher-multiple cyclical tech proxy for 3-6 months. Thesis: LRCX has more underappreciated multi-year optionality if NAND capex turns in 2027-2028, while the short leg cushions any sector-wide multiple compression.
• Add exposure to the second-order winners: consider a basket long in AMAT/LRCX suppliers or related equipment materials names for 6-12 months. These often lag the first leg of a WFE re-rating and can outperform once booking momentum becomes visible.
• For traders, sell downside puts in AMAT only if comfortable owning on a 10-15% drawdown. Implied vol likely remains elevated, and the market is rewarding positive revisions; downside should be defended unless guidance confidence breaks.
• Avoid chasing MS as a direct expression of this view; it is a low-conviction spillover beneficiary. Better used as a financing short in a sector pair if semicap enthusiasm broadens too far beyond the equipment complex.